I want to thank the two witnesses for meeting with us today. The information they have provided is fairly new, as it has not been brought to the committee's attention until now. I appreciate the fact that the information is coming from two members of the scientific community.
Since the beginning of the study, it has been pointed out that scientific research on this issue is lacking—and you also mentioned that—either when it comes to the health benefits or the health risks involved. The Canadian government has had a medical marijuana program for several years. However, the medical use of marijuana is not supported by scientific evidence. That is why I am very grateful for your personal and collective contributions.
My first question is about the program I mentioned.
Health Canada published a document titled Information for Health Care Professionals, which outlines the scientific knowledge on the use of cannabis and cannabinoids in the treatment of a host of diseases. The document also discusses adverse effects.
Do you think this document does a good job of taking into account the scientific literature on marijuana's potential therapeutic uses and side effects?